微细胞在英国家族性痴呆症中产生氨基基基ABri
bioRxiv : the preprint server for biology
|July 10, 2023
概括
微质,而不是神经元,在家族性英国痴呆症 (FBD) 中产生粉样蛋白形成. 这表明这些免疫细胞可能会启动神经退行,并在FBD和阿尔茨海默病的发病过程中发挥作用.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- ITM2B基因的突变导致家族性英国痴呆症 (FBD),其特征是粉样蛋白-Bri (ABri) 斑块和神经退行.
- 在FBD病变发生过程中,ABri的精确分子机制和细胞来源尚不清楚.
- FBD与阿尔茨海默病具有病态特征,强调需要了解其潜在机制.
结论:
- 微质细胞是英国家族性痴呆症中形成粉样蛋白的主要生产者.
- 微质细胞可能起到FBD神经退行症的诱导作用,有助于疾病的发病.
- ITM2B/BRI2在微质激活中的作用表明,它可能参与神经退行性疾病 (如FBD和阿尔茨海默氏症) 中的先天免疫反应.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Alzheimer's Disease: Overview
525
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525


